Liminal BioSciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LMNL and buy or sell other stocks, ETFs, and their options commission-free!About LMNL
Liminal BioSciences, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using drug discovery platform and a data driven approach.
CEOBruce Philip Pritchard
CEOBruce Philip Pritchard
Employees—
Employees—
HeadquartersLaval, Québec
HeadquartersLaval, Québec
Founded1994
Founded1994
Employees—
Employees—
LMNL Key Statistics
Market cap19.82M
Market cap19.82M
Price-Earnings ratio27.62
Price-Earnings ratio27.62
Dividend yield—
Dividend yield—
Average volume16.36K
Average volume16.36K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.50
52 Week high$8.50
52 Week low$3.10
52 Week low$3.10
Stock Snapshot
The current Liminal BioSciences(LMNL) stock price is $8.50, with a market capitalization of 19.82M. The stock trades at a price-to-earnings (P/E) ratio of 27.62.
Liminal BioSciences(LMNL) stock opened on 2025-11-17 at —. The price climbed to — and dipped to —.
The Liminal BioSciences(LMNL)'s current trading volume is 0, compared to an average daily volume of 16.36K.
During the past year, Liminal BioSciences(LMNL) stock moved between $3.10 at its lowest and $8.50 at its peak.
During the past year, Liminal BioSciences(LMNL) stock moved between $3.10 at its lowest and $8.50 at its peak.
People also own
Based on the portfolios of people who own LMNL. This list is generated using Robinhood data, and it’s not a recommendation.